Recover Investment Losses: Class Action Initiated Against V.F. Corporation (VFC)

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your V.F. Corporation (NYSE:VFC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/v-f-corporation-lawsuit-submission-form?prid=173262&wire=1&utm_campaign=24 […]

Levi & Korsinsky Notifies KBR, Inc. (KBR) Shareholders of Class Action Lawsuit and November 18, 2025 Deadline

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your KBR, Inc. (NYSE:KBR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kbr-inc-lawsuit-submission-form?prid=173260&wire=1&utm_campaign=15

Lost Money on Fortinet, Inc. (FTNT)? Contact Levi & Korsinsky to Join Class Action Before November 21, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Fortinet, Inc. (NASDAQ:FTNT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortinet-inc-lawsuit-submission-form?prid=173261&wire=1&utm_campaign=20

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galiano Gold Inc. – GAU

NEW YORK, NY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Galiano Gold Inc. ("Galiano" or the "Company") (NYSE:GAU). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Galiano and certain of its officers and/or

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. – LRMR

NEW YORK, NY, NY / ACCESS Newswire / October 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Larimar Therapeutics, Inc.("Larimar" or the "Company") (NASDAQ:LRMR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Larimar and certain of its officers and/or directors

LNTH Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Lantheus Holdings, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Lantheus Holdings, Inc.(“Lantheus”) (NASDAQ: LNTH) on behalf of those who purchased or otherwise acquired Lantheus securities between February 26, 2025, and August 5, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is

Canadian Investment Regulatory Organization Trading Halt – RBX.WT

The following issues have been halted by CIRO Company: Robex Resources Inc. TSX-Venture Symbol: RBX.WT All Issues: No Reason: Pending Delisting Halt Time (ET): 10:14 am CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and

SVRA LAWSUIT ALERT: Levi & Korsinsky Notifies Savara Inc. Investors – Lead Plaintiff Deadline November 7, 2025

NEW YORK CITY, NY / ACCESS Newswire / October 21, 2025 / NEW YORK, NY / ACCESS Newswire / October 21, 2025 / If you suffered a loss on your Savara Inc. (NASDAQ:SVRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/savara-inc-lawsuit-submission-form?prid=173259&wire=1&utm_campaign=7

Is BTC/DOGE/XRP skyrocketing or is it a bubble? Industry insiders offer their latest analysis!

Cumbria, England, Oct. 21, 2025 (GLOBE NEWSWIRE) — The modern fast-growing digital economy makes individuals more willing to get effortless and effective methods of earning money. Among the Rush of information, Berry is a product with a different idea, as it is not only an ingenious news aggregation and data analysis application, It is also

Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics

Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer, Philip Beer, will be presenting data on the identification of a CTPS1-dependent synthetic lethality in solid tumours at the 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer

Scroll to Top